Your browser doesn't support javascript.
loading
Anaplastic Thyroid Carcinoma, Version 2.2015.
Haddad, Robert I; Lydiatt, William M; Ball, Douglas W; Busaidy, Naifa Lamki; Byrd, David; Callender, Glenda; Dickson, Paxton; Duh, Quan-Yang; Ehya, Hormoz; Haymart, Megan; Hoh, Carl; Hunt, Jason P; Iagaru, Andrei; Kandeel, Fouad; Kopp, Peter; Lamonica, Dominick M; McCaffrey, Judith C; Moley, Jeffrey F; Parks, Lee; Raeburn, Christopher D; Ridge, John A; Ringel, Matthew D; Scheri, Randall P; Shah, Jatin P; Smallridge, Robert C; Sturgeon, Cord; Wang, Thomas N; Wirth, Lori J; Hoffmann, Karin G; Hughes, Miranda.
J Natl Compr Canc Netw ; 13(9): 1140-50, 2015 Sep.
Article en En | MEDLINE | ID: mdl-26358798
ABSTRACT
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Thyroid Carcinoma focuses on anaplastic carcinoma because substantial changes were made to the systemic therapy recommendations for the 2015 update. Dosages and frequency of administration are now provided, docetaxel/doxorubicin regimens were added, and single-agent cisplatin was deleted because it is not recommended for patients with advanced or metastatic anaplastic thyroid cancer.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Carcinoma Anaplásico de Tiroides Tipo de estudio: Guideline Idioma: En Revista: J Natl Compr Canc Netw Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Carcinoma Anaplásico de Tiroides Tipo de estudio: Guideline Idioma: En Revista: J Natl Compr Canc Netw Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article